Case Report: Structural Changes in the Coronary Vessel Wall in a Patient With Incomplete Kawasaki Disease

Takamichi Ishikawa1, Hiroki Uchiyama1, Satoshi Mogi2

  • 1Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Insights

Optical coherence tomography (OCT) revealed coronary artery wall changes in a patient with incomplete Kawasaki disease (KD) without aneurysms. This highlights OCT

Area of Science:

  • Cardiovascular Imaging
  • Pediatric Rheumatology
  • Vascular Biology

Background:

  • Kawasaki disease (KD) is a pediatric vasculitis affecting medium-sized vessels, posing risks for coronary artery lesions (CAL).
  • Conventional imaging like cardiac catheterization has limitations in visualizing detailed coronary artery anatomy.
  • Optical coherence tomography (OCT) offers high-resolution intracoronary imaging, distinguishing coronary arterial wall layers.

Observation:

  • A case report details an 11-year-old girl with incomplete KD without coronary artery aneurysms.
  • The patient did not receive intravenous immunoglobulin (IVIG) due to not meeting treatment criteria.
  • Transthoracic echocardiography showed no dilatation or aneurysms; cardiac catheterization and angiography confirmed no significant coronary artery abnormalities.

Findings:

  • Optical coherence tomography (OCT) revealed intimal thickening, media disruption, and neovascularization in the left anterior descending artery.
  • These findings represent structural changes in the coronary artery wall.
  • Coronary artery abnormalities were detected by OCT despite the absence of aneurysms or dilatation on conventional imaging.

Implications:

  • OCT can detect subclinical coronary artery structural changes in incomplete Kawasaki disease, even without aneurysms.
  • This imaging modality may be valuable for evaluating patients with incomplete KD who do not receive IVIG treatment.
  • OCT provides insights into vascular remodeling in KD, aiding in understanding long-term cardiovascular risks.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...